DAX-0,05 % EUR/USD+0,14 % Gold+0,19 % Öl (Brent)-0,72 %

AxogenAktie

ISIN: US05463X1063 | WKN: A1JMHK
15,000
 
EUR
12:05:03 Lang & Schwarz
-0,33 %
-0,050 EUR
Geldkurs 12:05:03
14,800 EUR
797 Stk.
Briefkurs 12:05:03
15,200 EUR
797 Stk.
Mehr Daten anzeigen
NewsFlashAnzeige
Hammernews - jetzt ist es raus - renommierte Minen-Experten engagieren sich bei U.S. Gold!

Axogen Chart

Neuigkeiten zur Axogen Inc Aktie

ZeitTitel
04.12.19

Avance Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade Float
11.03.19

AXOGEN 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit against AxoGen, Inc. - AXGN
09.03.19

AXOGEN 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit against AxoGen, Inc. - AXGN
07.03.19

Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Axogen, Inc. and March 11 Lead Plaintiff Deadline
05.03.19

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against AxoGen, Inc.
20.02.19

AXGN REMINDER NOTICE: Rosen Law Firm Reminds AxoGen, Inc. Investors of Important Deadline in Securities Class Action Lawsuit
16.02.19

AXOGEN SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AxoGen, Inc. - AXGN
12.02.19

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against AxoGen, Inc. – AXGN
05.02.19

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AxoGen, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
02.02.19

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against AxoGen, Inc. and Encourages Investors to Contact the Firm Before March 11
02.02.19

AXOGEN SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against AxoGen, Inc. - AXGN
24.01.19

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In AxoGen, Inc. To Contact The Firm
17.01.19

Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Axogen, Inc.
17.01.19

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against AxoGen, Inc.

Insidertrade: :
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Die neusten Nachrichten zu Axogen

ZeitTitel
04.12.19
Avance Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade Float
11.03.19
AXOGEN 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit against AxoGen, Inc. - AXGN
09.03.19
AXOGEN 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit against AxoGen, Inc. - AXGN
07.03.19
Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Axogen, Inc. and March 11 Lead Plaintiff Deadline
05.03.19
INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against AxoGen, Inc.
mehr Axogen Nachrichten »

Nachrichten aus der Branche Pharmaindustrie

ZeitTitel
12:01 Uhr
Aurinia Announces Public Offering of Common Shares
12:00 Uhr
Axonics Provides Survey Results from Physician Seminar Series Showcasing the Recently FDA Approved Axonics r-SNM System
11:45 Uhr
Aktien Frankfurt: Verhaltener Start in eine ereignisreiche Woche
11:41 Uhr
ANALYSE/Deutsche Bank: Carl Zeiss Meditec hat großes Wachstumspotenzial - 'Buy'
11:37 Uhr
Evotec macht Aktionären Sorgen: Ich erkläre Ihnen, wie hoch der Verlust ausfallen kann
mehr Branchennachrichten »

Indexzugehörigkeit von Axogen

WertpapierPerf. %
Nasdaq
+1,00
Russell 2000 (calculated by Bridge Data Services)
0,00
NASDAQ Health Care Index
+0,94
STOXX Developed Markets Total Market ESG-X Index (Price)
-0,07
Nasdaq DM Ex Korea Small Cap JPY Index Net Total Return
+0,66
NASDAQ OMX NASDAQ Composite Total Return Index
+1,07
iSTOXX FactSet Breakthrough Healthcare USD (Gross Return)
-0,09
Nasdaq DM Ex Korea CAD Index
+1,38
STOXX Developed Markets Total Market EUR (Price)
-0,07
iSTOXX FactSet Breakthrough Healthcare USD (Net Return)
-0,09
Alle zugehörigen Indizes »

Aktienkurs Axogen A1JMHK |

BörsenplatzLang & Schwarz
Letzter Kurs15,000EUR
Performance-0,33 %
Kurszeit12:05:03
Eröffnung15,050EUR
Tageshoch15,177EUR
Tagestief15,000EUR
Vortageskurs15,050EUR
52-Wochen Hoch27,30EUR
52-Wochen Tief9,934EUR
Performance 1 Monat+8,80 %
Performance 1 Jahr-42,24 %

Stammdaten zu Axogen

NameAxogen Inc
KurznameAxogen
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA1JMHK
BranchePharmaindustrie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl39,47 Mio.
Marktkapitalisierung592,03 Mio.EUR

Performance Axogen Aktie

ZeitKursPerf.
1 Tag15,000EUR
-0,33 %
1 Woche15,727EUR
-4,30 %
1 Monat13,833EUR
+8,80 %
3 Monate14,916EUR
+0,90 %
6 Monate18,241EUR
-17,49 %
Lfd. Jahr16,738EUR
-10,08 %
1 Jahr26,06EUR
-42,24 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameAxogen Inc
StadtAlachua, FL
LandUSA USA
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Axel Springer
-0,16
2.
TMW Immobilien Weltfonds P
0,00
 
3.
Axsome Therapeutics
+1,94
4.
Axon Enterprise
-0,95
5.
Axos Financial
+0,77
6.
Axonics Modulation Technologies
+2,65

Emissionsinformationen

Emissionsvolumen4.186.046Stück
ZeichnungsgebührNein
PlatzierungÖffentlich